NMTC - NeuroOne Medical Technologies Corporation

Other OTC - Other OTC Delayed Price. Currency in USD

NeuroOne Medical Technologies Corporation

7599 Anagram Drive
Eden Prairie, MN 55344
United States

IndustryMedical Devices
Full Time Employees4

Key Executives

NameTitlePayExercisedYear Born
Mr. David A. RosaCEO, Pres & Director558.17kN/A1964
Mr. Steven MertensChief Technology Officer255.56kN/A1964
Mr. Scott HeulerVP of SalesN/AN/A1964
Ms. Leah NoaeillSr. Director of MarketingN/AN/AN/A
Amounts are as of December 31, 2019 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


NeuroOne Medical Technologies Corporation, an early-stage medical technology company, focuses on the development and commercialization of thin film electrode technology. The company develops cortical and sheet and depth electrode technology to provide cEEG and stereoelectroencephalography recording, brain stimulation, and ablation solutions for patients suffering from epilepsy, Parkinson's disease, dystonia, essential tremors, and other related brain related disorders, as well as focus on the treatment of back-related pain from failed back surgeries. The company is based in Eden Prairie, Minnesota.

Corporate Governance

NeuroOne Medical Technologies Corporation’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.